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Transcription is a multi-stage process that coordinates several steps within the transcription 
cycle including chromatin reorganization, RnA polymerase II recruitment, initiation, promoter 
clearance  and  elongation.  Recent  advances  have  identified  the  super  elongation  complex, 
containing  the  eleven-nineteen  lysine-rich  leukaemia  (ELL)  protein,  as  a  key  regulator  of 
transcriptional elongation. Here we show that ELL has a diverse and kinetically distinct role 
before its assembly into the super elongation complex by stabilizing Pol II recruitment/initiation 
and entry into the pause site. Loss of ELL destabilizes the pre-initiation complexes and results 
in disruption of early elongation and promoter proximal chromatin structure before recruitment 
of AFF4 and other super elongation complex components. These changes result in significantly 
reduced transcriptional activation of rapidly induced genes. Thus, ELL has an early and essential 
role during rapid high-amplitude gene expression that is required for both Pol II pause site entry 
and release. 
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T
ranscription involves ordered assembly of transcriptional reg-
ulators and regulatory complexes that coordinate progressive 
changes in structure and activity of RNA polymerase II (Pol 
II), as it passes through the transcription cycle. These steps begin 
with the recruitment of Pol II to form the pre-initiation complex 
(PIC) through its assembly with general transcription factors and 
specific  promoter  proximal  transcriptional  co-regulators  includ-
ing the mediator complex1 and the histone acetyl-transferase p300   
(ref. 2), followed by transcription initiation, elongation, RNA process-
ing, termination and export3. Although, for many years, the recruit-
ment phase has been considered the major rate-determining step in   
transcription, recent studies show that Pol II is disproportionately 
accumulated in ‘poised’ or ‘stalled states’ at proximal promoters 
within 300 base pairs of the transcription start site of most mamma-
lian and lower metazoan genes4–7. This widespread occurrence of 
proximally stalled Pol II has shifted the focus to understanding how 
transcriptional elongation is governed in complex organisms8.
One component that has a central role in the release of Pol II 
from  pausing  is  the  positive  transcriptional  elongation  factor  b   
(P-TEFb), a heterodimeric kinase, composed of CDK9 and Cyclin T.   
P-TEFb,  disables  negative  regulators  of  transcription  and  modi-
fies Pol II at its Ser-2 carboxy-terminal domain (CTD) repeat by 
phosphorylation  (pS2)  to  license  assembly  of  multiple  factors 
critical for mRNA biogenesis and chromatin modification during 
transcription8. A second well-known component is the ELL. ELL 
was first identified as a fusion partner of the MLL gene in chromo-
somal translocations associated with mixed lineage leukaemias in 
children9 and shown later to increase elongation by reducing the 
rate of Pol II stalling during active transcription10. Recently, several 
groups have reported the in vitro identification of a higher order 
complexes  containing  ELL  and  P-TEFb  in  complex  with  multi-
ple MLL translocation partners, including AFF1 (AF4), ENL, AF9  
and AFF4 (AF5q31)11–15. The identification of this complex, referred 
to  as  the  super  elongation  complexes  (SECs),  has  highlighted   
the  complexity  of  transcription  and  has  led  to  several  unifying 
concepts linking the control of transcriptional elongation to gene 
regulatory  events  central  for  cellular  growth,  development  and   
leukaemogenesis11,13,15,16.
More recently, several reports have characterized the formation 
and differential activity of ELL-containing subassemblies of the SEC 
complex, indicating that SEC assembly and function may be much 
more dynamic than previously believed17–19. In this study, by kinet-
ically profiling the in vivo recruitment of ELL, RNA polymerase II, 
members of the PIC, and SEC components AFF4 and P-TEFb, we 
reveal a much earlier role for ELL in the transcription cycle before 
Pol II pause site entry. Reduction of endogenous ELL by gene deple-
tion not only leads to reduced SEC assembly and P-TEFb recruit-
ment, but results in destabilization and loss of Pol II and mediator 
components from the proximal promoter of rapidly induced genes 
during activated transcription. As a result, Pol II fails to enter the 
pause site, and there is attenuated accumulation of paused Pol II-
associated short nascent RNA, and an accompanying redistribution 
of nucleosome density at the proximal promoter. Gene expression 
analysis demonstrates that ELL is broadly required for inducible 
transcriptional activation of many genes involved in stress and sig-
nal-regulated responses, including most immediate early genes. In 
contrast, depletion of the AFF4 SEC component produces much 
smaller influences on transcription than loss of ELL and does not 
significantly impair ELL recruitment, PIC assembly, or Pol II pause 
site entry. Finally, live cell imaging analysis of ELL and AFF4 load-
ing at an endogenous gene array reveals that ELL and AFF4 load 
and reside at actively induced genes with different kinetics; there-
fore, they are likely to exist in multiple subassemblies distinct from 
a single large static complex. Together, these findings demonstrate 
that  ELL  has  an  essential  and  versatile  role  across  many  steps 
throughout the transcription cycle that are required to coordinate 
and synchronize the multiple rounds of PIC initiation/re-initiation 
with  subsequent  productive  elongation,  thus  enabling  rapid  and 
high amplitude gene expression.
Results
ELL is required for rapidly induced transcription. Several studies 
in different model systems have shown that ELL is required for Pol 
II Ser-2 CTD phosphorylation through its association with P-TEFb, 
and recent in vitro studies have revealed that this activity is linked 
to formation of the SEC through its co-assembly with AFF4 and 
AF9 family members13–15. However, the mechanism and dynamics 
of how ELL is recruited and functions to target these complexes to 
actively transcribing endogenous genes in mammalian cells is not 
clear. To begin to address these questions, we used a combination 
of  gene  expression,  chromatin  immunoprecipitation,  and  gene 
depletion strategies to profile ELL function at endogenous genes. 
By chromatin immunoprecipitation, the kinetic distribution of ELL 
within the promoter and transcribed regions of FOS and LDLR 
parallels the transcription of their respective mRNAs in mitogen 
(EGF)-induced  HEK293  cells  (Fig.  1a,b).  ELL  RNAi  depletion 
results in global loss of both Pol II pS2 and elongation-associated 
histone H3K36Me3 tri-methylation (Fig. 1c). Notably, by microarray 
analysis, ELL gene depletion results in genome-wide loss of inducible 
expression of multiple genes involved in rapid stress and stimulus 
evoked gene expression in HEK293 cells (Fig. 1c–e; Supplementary 
Table S1), including the immediate early genes FOS, LDLR, EGR2 
and EGR3 (Fig. 1f).
ELL recruits AFF4/P-TEFb complexes to rapidly induced genes. 
A central observation that links MLL translocation partners to the 
regulation of transcriptional elongation during leukaemogenesis is 
their recursive interactions with each other and P-TEFb. This is sup-
ported by recent in vitro findings that complexes containing ELL, 
P-TEFb and the MLL translocation partner, AFF4, are stabilized by 
both Tat and CDK9 and can form a variety of stable intermediates 
with  differential  transcriptional  activity13–15,17,18.  The  consensus 
from these biochemical studies is that AFF4 functions to ‘scaffold’ 
these  interactions  through  contiguous  amino-terminal  domains 
that bind CDK9 (refs 11, 12, 14, 16, 20), CTDs that bind ELL14 and 
recently recognized interactions between Cyclin T and ELL17. How-
ever, despite the observation that ELL, P-TEFb and AFF4 are capa-
ble of forming a holocomplex, the patterns of the assembly of these 
factors are not identical (Fig. 2; Supplementary Fig. S1). Notably, the 
EGF-induced loading and distribution of ELL at the promoter and 
into the transcribed regions of immediate early genes shows relative 
enrichment in both regions (Fig. 2). This pattern is significantly less 
prominent for P-TEFb (Fig. 2) but consistent with its recruitment 
to the promoter by other transcription factors (for example, Myc, 
NF-kappa B, and Brd4 (refs 21–23)). In contrast, mitogen-induced 
recruitment of AFF4 shows primarily progressive 3′ enrichment for 
AFF4 (Fig. 2). The differences in these patterns suggest that ELL, 
P-TEFb and AFF4 may participate in separate assemblies before 
SEC formation. Nonetheless, in all cases, ELL depletion leads to   
significant loss of both P-TEFb and AFF4 recruitment following 
EGF induction (Fig. 2, black and white columns).
ELL is required for PIC assembly and function. Abrogated recruit-
ment of SEC components P-TEFb and AFF4 after ELL depletion 
was expected. Surprisingly, however, ChIP studies of Pol II assem-
bly, at immediate early genes, also reveal that PIC formation and 
subsequent CTD phosphorylation are also severely impaired by ELL 
depletion in EGF-stimulated cells (Fig. 3; Supplementary Fig. S2). 
This significant decrease in the promoter proximal Pol II is readily 
evident by the paradoxical change in the pausing index24 (Fig. 3b, 
inset) in EGF-stimulated cells following ELL depletion. The absence 
of Pol II progression into the transcribed regions, accompanying Pol ARTICLE     
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II (pS2) phosphorylation, and loading of the Cdk7 subunit of TFIIH 
(Fig. 3) and Pol II serine 5 phosphorylation (pS5) (Supplementary 
Fig. S3), indicate that ELL depletion produces a sweeping abroga-
tion of Pol II recruitment and function, spanning multiple phases 
of PIC formation and early initiation during EGF induction of FOS, 
EGR2 and EGR3.
ELL forms distinct complexes with AFF4 and p300. The finding 
that ELL is required for both elongation factor recruitment and PIC 
formation suggests that ELL may interact with components of the 
PIC. In addition to ELL, prior studies have shown that p300 is also 
required for the activation of rapidly induced genes and both are   
rapidly recruited to gene promoter regions with similar kinetics7. 
Co-immunoprecipitation studies show that, in addition to Cdk9, 
ELL forms a direct complex with p300 in nuclear extracts from both 
resting and mitogen-induced cells (Fig. 4a). Moreover, cells depleted 
of p300 by RNAi (Fig. 4b,c) or by gene knockout (Supplementary   
Fig. S4) show a major deficit in ELL recruitment following EGF 
stimulation, indicating a significant role for ELL/p300 interactions 
in ELL recruitment and stabilization of PIC assembly. In contrast, 
loss of ELL impairs neither p300 nor TBP recruitment (Fig. 4c), 
suggesting that ELL may assemble at later stages of PIC formation 
to stabilize the transition from initiation to early elongation during 
activated transcription. Consistent with this, glycerol gradient sedi-
mentation analysis of nuclear extracts identifies separate popula-
tions of ELL co-migrating both with p300 as a smaller complex, and 
with AFF4 and other P-TEFb components as the larger SEC com-
plex (Fig. 4d; Supplementary Fig. S5). This interaction is demon-
strated functionally by reporter assays, using a tethered Gal4–p300 
fusion, to reveal that p300-driven transcriptional activation in the 
presence of CDK9 is highly synergistic with ELL (Fig. 4e).
We used domain-dependent profiling to gain further insight into 
the multiple interactions coordinated between ELL and components 
of the PIC and SEC (Fig. 4f; Supplementary Fig. S6). Epitope-tagged 
truncation mutants of ELL reveal that, although multiple domains 
of ELL, including the N-terminal (1–210 aa), mid-portion (207–
411aa) and C-terminal (410–621) domains, are capable of interact-
ing with Pol II, only the C-terminal ELL domain, or full length ELL 
form complexes with p300, P-TEFb and AFF4 (Fig. 4f). Prior studies 
have shown that the bromodomain protein Brd4 also interacts with 
P-TEFb to target it to active genes7,25. However, although both ELL 
and Brd4 are avidly co-recruited to active promoters7, they appear 
to form independent complexes in cellular extracts (Fig. 4f; Supple-
mentary Fig. S5), as has been suggested by prior studies14,15. Finally, 
although recent studies have regarded ELL and its ELL2 paralogue 
as interchangeable, the nature of their interaction or whether they 
assemble in the same complex remains unclear13,14,19,26. Immu-
noprecipitation of endogenous complexes in cells depleted of ELL 
reveals a significant role for ELL in maintaining the integrity of 
the SEC complex bacause its depletion reduces the levels of AFF4 
associated with immunoprecipitated CDK9 (Fig. 4g). Even though 
the ELL2 paralogue readily forms complexes with AFF4, its lev-
els do not compensate for ELL depletion; thus, ELL2-containing   
complexes seem to assemble independent of ELL (Fig. 4g).
ELL facilitates recruitment of PIC mediator components. Rapid 
high-amplitude transcription requires that the re-initiation complex 
assembles quickly and efficiently. The residual PIC components that 
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remain following Pol II promoter escape is referred to as the scaf-
fold PIC, and the mediator complex has a central role in its stability 
and function1,27. Consistent with its requirement for PIC stability, 
cells depleted of ELL show a marked decrease in both Med 1 and 
CDK8 mediator components following EGF stimulation (Fig. 5a,b; 
 Supplementary Fig. S7). Thus, multiple dynamic members of the 
PIC assembly, including components of mediator thought to facili-
tate rapid transition to elongation (CDK8)28, show impaired recruit-
ment to actively induced genes in the absence of ELL.
ELL  is  required  for  promoter  clearance  and  pause  site  entry. 
Recent genome-wide studies have shown that Pol II pausing and 
abortive elongation are often associated with accumulation of short-
capped nascent RNA transcripts generated by stalled polymerases5. 
To test whether ELL is required for events during early elongation, 
the levels of short-capped nascent RNAs were detected using the 
method described by Nechaev et al.5 (Fig. 5c). Strikingly, loss of ELL 
results in a significant decrease in the formation of short-capped 
RNAs during mitogen induction of FOS, EGR3, EGR2, LDLR and 
BRCA1 (Fig. 5d-e). These observations support the finding that ELL 
is required during early elongation in a manner that is distinct from 
its role in releasing Pol II from stalling by recruitment of P-TEFb 
and AFF4 (Fig. 2)13–15.
ELL exists in functional complexes independent of AFF4. The 
early function for ELL in promoter clearance and pause site entry 
is in distinct contrast to the much later sequential role AFF4 had. 
AFF4 depletion shows little influence on the accumulation of nas-
cent-capped short RNA transcripts following mitogen induction 
(Fig. 6a,b). Consistent with this observation, AFF4 depletion shows 
modest effects on P-TEFb recruitment and insignificant influence 
on ELL recruitment at FOS, EGR3 and EGR2 (Fig. 6c). Accord-
ingly,  AFF4  depletion  is  much  less  effective  in  decreasing  tran-
scription of FOS, EGR3, EGR2, LDLR, JUN and BRCA1 (Fig. 6d)   
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in comparison to depletion of ELL (Fig. 1f). Finally, live cell imag-
ing of GFP-tagged AFF4 and ELL loading at the MMTV array29 in 
glucocorticoid-stimulated cells reveal different fluorescent recov-
ery after photobleaching (FRAP) profiles demonstrating that ELL 
and AFF4 do not exist exclusively in a single static complex and 
are, therefore, likely to have both overlapping and distinct roles 
throughout the transcription cycle (Fig. 6e).
ELL  loss  disrupts  local  histone  density  and  modifications.  To 
assess whether or not depletion of ELL can influence histone marks 
and nucleosomal structure at mitogen-inducible genes, the distri-
bution of total histone, the activation-associated histone H3K4Me3 
tri-methylation  mark  and  the  elongation-associated  histone 
H3K36Me3 tri-methylation mark were profiled across the promoter 
and transcribed regions of FOS, EGR3 and EGR2 in cells depleted 
of ELL before mitogen stimulation (Fig. 7; Supplementary Fig. S8). 
As demonstrated in Fig. 7, loss of ELL results in depletion of histone 
H3K4Me3 activation marks at the proximal promoter of mitogen-
induced genes, and this reduction is associated with an increase in 
total histone 4 densities within the proximal promoter, suggesting 
the licensing of a more repressive chromatin state in the absence   
of  ELL.  In  addition,  and  consistent  with  the  role  of  ELL  as  an   
elongation  factor,  the  elongation-associated  histone  H3K36Me3   
tri-methylation marks are significantly repressed in the absence of 
ELL (Fig. 7). Notably, this redistribution resembles other cellular 
systems in which the paused or promoter proximal RNA polymer-
ase II is destabilized30–32.
Discussion
In this study, we show that ELL has multiple distinct roles in the 
hierarchy of transcriptional events leading to production of mature 
RNA transcripts. These functional roles, in processes that span both 
early and late transcriptional events, are reminiscent of the ability 
of TFIIF and TFIIS to control steps in both transcriptional initia-
tion and elongation3,33. One of the most interesting findings in this 
study is the early role of ELL in stabilizing the re-initiation complex 
and early elongation. This step is very distinct from its later role 
in recruiting P-TEFb and other SEC-associated complexes to the 
elongating polymerase and suggests that ELL, like TFIIF and TFIIS, 
may actively shuttle between different transcriptional states of Pol II 
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(refs 3, 34). It is noteworthy that these findings are not incompatible 
with the in vitro detection of ELL in large molecular weight com-
plexes13,15, but rather serve to illustrate that the assembly of these 
transcriptional complexes is likely to be a highly dynamic, rather 
than static, process. Thus, it is more feasible that in vivo higher order 
complexes containing ELL assemble sequentially and dynamically 
at endogenous genes rather than engaging promoters as pre-assem-
bled ‘supercomplexes’. Therefore, our findings are consistent with a 
molecular scenario in which ELL assembles first with the initiat-
ing polymerase at the proximal promoter, where it helps to establish 
interactions between Pol II, mediator and p300 during early elon-
gation. This step serves both to stabilize the re-initiation complex 
for subsequent rounds of transcription, and to later position ELL 
so that it can act as a platform to enable the subsequent recruitment 
of P-TEFb and AFF4 to the pre-elongation complex (Fig. 8). This 
sequential model is consistent with the finding that early elongation 
is impaired by loss of ELL but not AFF4.
An extra novel finding in this study is a possible role for ELL 
in stabilizing recruitment and assembly of the Med1 component of 
mediator. These findings are highly consistent with recent obser-
vation that the Med26 component of the mediator complex can 
function to recruit ELL/EAF containing complexes to the PIC com-
plex18. Similar to the study by Biswas et al.,17 this study also sug-
gested that there may be multiple ELL containing complexes that 
have differential functional activity18. Notably, the differential func-
tion of ELL-containing complexes separate from AFF4 is suggested 
in recent genome-wide profiling in mouse embryonic stem cells that 
show a distinct and separate peak for AFF4 downstream of ELL2   
(ref. 19). Which mechanisms and kinetics underlie this activity at both 
the PIC and re-initiation complex of rapidly induced endogenous 
genes will require extensive future investigation. It is important to 
note that Med1 is a very dynamic component of the mediator complex 
that interacts with a variety of transcription factors and nuclear hor-
mone receptors and is a target for mitogen-induced post-translational 
modification35. Thus, the potential for the regulation of ELL interac-
tion with the PIC complex by a variety of signalling pathways is enor-
mous. Finally, recent studies by Biswas et al. also suggest that other 
components of SEC like AF9 may also have roles at earlier stages of 
transcription17. Therefore, ELL is not likely to be the only member of 
the SEC complex with multiple distinct roles across the transcription 
cycle. Clearly, a lot remains to be understood about this new function 
for ELL in the transcription cycle and, by association, the differential 
role of mediator and SEC components during early elongation.
The finding that loss of ELL, like loss of NELF, results in destabi-
lization of promoter proximal Pol II, and a shift of histone density 
into the proximal promoter is very provocative, and suggest that, 
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depending on promoter context, NELF may have a more positive 
role in enhancing transcription by stabilizing the PIC at points of 
transition to early elongation. It should be noted that loss of ELL 
also  reduces  recruitment  of  NELF  to  the  proximal  promoter  of 
mitogen-induced  genes  (J.S.B.,  unpublished  observation).  None-
theless, further kinetic studies will be needed to dissect the precise 
dynamics of this interaction.
The  discovery  and  identification  of  the  web  of  interactions 
demonstrated by MLL fusion partners has generated new insights 
into  understanding  the  regulation  of  transcriptional  elongation;   
however, more needs to be learned about the mechanisms gov-
erning how different MLL translocation partners are assembled at 
genes in physiological and leukaemic backgrounds and what their 
true  molecular  functions  are  at  endogenous  genes.  The  finding 
that ELL has roles much earlier in the transcription cycle suggests 
that the mechanism of action of MLL translocation partners may 
be more divergent and stratified than previously perceived. Each 
leukaemogenic MLL fusion may have particular molecular features   
–
ELL
shRNA
– +
Control
shRNA
+
Upstream Promoter Exon/intron
Exon4
FOS
Total nuclear
RNA
Short nuclear
RNA
Short capped
nuclear RNA
15% Urea-PAGE
size selection
RNA 5′ terminator
Exonuclease
Exon2
Exon2
EGR2
EGR3
BRCA1
LDLR
Intron1
Intron2
EGR2
0
100
200
300
c d
e
a b
CDK8 
C
hI
P
(relative to NS IgG)
2
4
6
8
12
10
FOS
Promoter
Exon
2
4
6
8
Promoter
Exon
2
3
5
1
4
6
Promoter
Exon
EGR3
+EGF
+EGF
–
–
shELL
0h EGF
shELL
1h EGF
Control
0h EGF
Control
1h EGF
– – + EGF
FOS
0
2
4
6
8
10
12
Med1 ChIP
(input normalized) 
+ – – + +
EGR3
0
2
4
6
8
EGF – – + EGF
EGR2
0
1
2
3
4
5
6
7
+
– – + +
ELL
shRNA
Control
shRNA
0
1
2
3
4
5
6
TFIIB ChIP
(input normalized)
EGF – – + +
0
1
2
3
4
5
6
7
ELL
shRNA
Control
shRNA
EGF – – + +
ELL
shRNA
Control
shRNA
0
1
2
3
4
5
EGF
–
ELL
shRNA
– +
Control
shRNA
EGF
Fold increase, qRT–PCR
(normalized to 
RNU5 )
0
100
200
300
400
500 FOS
+ –
ELL
shRNA
– +
Control
shRNA
+
0
100
200
300
400
500
600
EGR3
EGF
–
ELL
shRNA
– +
Control
shRNA
+
BRCA1
0
100
200
300
EGF –
ELL
shRNA
– +
Control
shRNA
+
Fold increase, qRT–PCR
(normalized to  RN
U
5
)
LDLR
0
400
800
1200
EGF
EGF
EGR2
Figure 5 | ELL is required in post-recruitment steps before commitment to productive elongation. (a) ChIP enrichment of med1 and TFIIB at the 
promoter (white and blue bars) and transcribed regions (black and red bars) of the FOS, EGR3, and EGR2 genes in resting or EGF-stimulated HEK293 cells 
before (white and black bars) and after ELL depletion by RnAi (blue and red bars). Error bars show the range of error for n = 2 biological replicates.  
(b) ChIP enrichment of CDK8 at the promoter and transcribed regions of the FOS, EGR3 and EGR2 genes in resting (grey and blue bars) or EGF-stimulated 
(black and red bars) HEK293 cells before (blue and red bars) and after ELL depletion by RnAi (white and black bars). Average range of error is 14.7 % 
of the mean from n = 2 biological replicates. (c) Experimental scheme for short nascent RnA detection. (d) schematic of primer location for detection of 
profiles of short nascent RnA from the FOS, EGR3, EGR2, LDLR and BRCA1 genes. White bar indicates regions upstream of the promoter. Black bars indicate 
promoter regions. Grey bars indicated downstream intron/exon regions. (e) Profile of short nascent RnA from FOS, EGR3, EGR2, LDLR and BRCA1 genes 
in resting and EGF-stimulated HEK293 cells before and after ELL depletion by RnAi. Levels were normalized to RNU5 RnA. Error bars show the range of 
error for n = 2 biological replicates.ARTICLE

nATuRE CommunICATIons | DoI: 10.1038/ncomms1652
nATuRE CommunICATIons | 3:633 | DoI: 10.1038/ncomms1652 | www.nature.com/naturecommunications
© 2012 Macmillan Publishers Limited. All rights reserved.
and factor dependencies that will prove highly relevant for future 
exploitation in molecular treatment strategies tailored to individ-
ual MLL translocation partners. Notably, the finding that ELL also 
interacts with p300, another well-known translocation partner of 
MLL in MLL leukaemias36 confirms the existence of yet another 
node in the ‘MLL web’37 of interactions.
Finally, the global gene expression profiling suggests an essential 
role for ELL in the expression of rapidly induced genes to facilitate 
quick responses to environmental cues. Interestingly, this parallels 
the recently uncovered positive role for CKD8 at immediately early 
genes28, thus suggesting a selective interaction between ELL and 
CDK8-containing mediator complexes during such events. In any 
regard, these are precisely the type of cellular programmes that were 
predicted to require or utilize paused polymerases to enable rapid 
response from ‘poised’ states. Although this trend was first uncov-
ered in earlier genome-wide studies of paused polymerases38,39,   
it highlights the potential role for ELL in developmentally regulated 
gene expression programs at multiple steps throughout the loading 
and release of productively elongating Pol II at targeted genes.
Methods
Cell lines and transfection. Jurkat T and HEK293 cells were grown in RPMI 
medium supplemented with 10% FCS and 100 U ml − 1 penicillin and streptomycin 
(Invitrogen) in a humidified atmosphere at 37 °C with 5% CO2 (ref. 7). Plasmids 
expressing each Flag epitope-tagged ELL (f-ELL1-621), ELL truncation mutants 
(ELL1-210; ELL207-411; ELL410-621), and Brd4 (f-Brd4) were used23,40. Vectors 
expressing Flag-tagged CDK9 were generously provided by Dr Sergei Nekhai 
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(Howard University). Transfections were performed using Lipofectamine 2000 
(Invitrogen) according to the manufacturer’s instructions. The EGFP–ELL (GFP–
ELL) and EGFP–AFF4 (GFP–AFF4) constructs were generated by ligating ELL and 
AFF4 cDNA (OriGene) into a pEGFP-C2 (Clontech) vector as EcoRI-KpnI and 
XhoI-BamHI fragments, respectively. The pE-Cherry-FP-C1-GR construct was 
generously provided by Gordon Hager, National Cancer Institute, Bethesda. The 
3134 cell line is a subclone of 904.13 derived from a mouse mammary adenocar-
cinoma cell line, C127 and harbours a large tandem array of ~200 copies of the 
mouse mammary tumour virus promoter driving Ha-v-ras expression in a head-to-
tail orientation29 provided by Gordon Hager, National Cancer Institute, Bethesda.
Immunoprecipitation and glycerol gradient sedimentation. Immunoprecipita-
tion was carried out with 108 Jurkat cells for each condition (control and stimu-
lated with 50 ng ml − 1 PMA and 1 µM Ionomycin as indicated) or 2×106 HEK293 
transfected with Flag-tagged expression vectors. Nuclear extracts and whole cell 
lysates were generated as described previously41. Glycerol ultracentrifugation 
(Beckmann SW 60Ti, 20 h at 272,400×g) was performed as previously described23. 
Nuclei (2×108 cells), isolated by the method of Dignam and Roeder, were sonicated 
at 4 °C (Diagenode Bioruptor, 6 cycles on 6 cycles off) in buffers containing 10 mM 
HEPES, pH 7.9, 200 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA and 4 mM beta-mer-
captoethanol, and clarified by centrifugation at 100,000g for 30 min at 4 °C, before 
loading onto 10–40% glycerol gradients. Antibody conditions used for immuno-
precipitation and western blotting are provided in Supplementary Table S2.
Chromatin immunoprecipitation and RNAi. HEK293 wild-type (WT) and ELL 
KD cells were stimulated with EGF (50 ng ml − 1) (Peprotech) for 1 hr, fixed 5 min 
in 1% formaldehyde at 4 °C, quenched and collectted for chromatin immuno-
precipitation.
The cross-linked cell pellets (1×107) were thawed on ice, resuspended in 1 ml 
of low-salt IP buffer (150 mM NaCl, 50 mM Tris–HCl (pH 7.5), 5 mM EDTA, 0.5% 
Nonidet P-40, and 1% Triton X-100) with 1× protease inhibitor mixture (Sigma-
Aldrich), and sonicated for 4 min (20 s ‘on’ and 30 s ‘off’) at 3.0 power output using 
a Misonix Sonicator 3000 (Misonix)7. Total RNA was prepared using the Qiagen 
RNAeasy Kit following the manufacturer’s instructions. RT reactions were per-
formed with Omniscript (Qiagen) following the standard protocol7. (Primers used 
are provided in the Supplementary Materials). For RNAi studies, transfections were 
performed in 6 wells and 10-cm culture vessels using plasmids expressing ELL- and 
AFF4-specific shRNA (Open Biosystem). HEK293 cells (6.0×105 in 6 wells and 
5×106) were transfected with ELL shRNA and Lipofectamine 2000 reagent with 
varying concentrations (4 and 8 µg) of plasmid DNA and the ratio of DNA and 
Lipofectamine 2000 (1:0.5 to 1:5). Non-targeting pGIPz shRNA was used as a 
control. Antibodies and primers used for the analysis are provided in Supplemen-
tary Tables S2–S4.
Gene expression microarray. Total RNA from unstimulated WT and ELL KD 
HEK293 and stimulated (EGF, 50 ng ml − 1) WT and ELL KD HEK293 cells were 
isolated and purified using the Qiagen RNAeasy Kit following the manufacturer ’s 
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instructions7 and submitted to LMT-Affymetrix microarray facility to obtain the 
raw data (NCI-Frederick). The microarray data has been deposited in the GEO 
database under the GSE34104.
Expression profiling by Affymetrix exon microarray analysis. Affymetrix  
Human Exon ST1.0 platform was used for the microarray analysis. Raw data in 
CEL files were preprocessed using Affymetrix Expression Console software with 
‘RMA polish/RMA’ option and its median normalization method. ‘Core’ confi-
dence was used for the exon annotation. We profiled expression of each sample in 
biological duplicates. The exon-level value was taken to be the average of the two 
biological replicates. The gene-level expression value was obtained by taking the 
mean of the two exons with the highest signal intensity for the transcript.
Preparation and detection of short-capped RNA. The total RNA from HEK293 
WT and ELL KD cells after transfection were isolated with ZR RNA MiniPrep 
(ZYMO Research). Short RNAs (50–250bp) were purified on 15% TBE UREA gel 
(Invitrogen) and recovered with ZR small-RNA PAGE Recovery Kit (Invitrogen). 
Purified short RNA was treated with the Terminator 5′-Phosphate-Dependent 
Exonuclease to remove uncapped 5′ RNA and then reverse transcribed to produce 
the cDNA with Quantitect Reverse Transcription Kit (QIAGEN). RNU5 was used 
as a loading control for quantitative PCR. Primer used for the analysis are provided 
in Supplementary Table S5.
Live-cell imaging and FRAP. Before live-cell imaging, 3134 cells were plated in 
coverglass bottom chambers (Lab-Tek) containing Phenol Red-free RPMI (Gibco 
BRL) supplemented with 10% charcoal-stripped fetal bovine serum (Atlanta 
Biologicals). The 3134 cells were transiently co-transfected using Lipofectamine 
2000 according to the manufacturer’s protocol (Invitrogen) to express mCherry-GR 
and either EGFP–ELL or EGFP–AFF4. The 3134 cells transiently expressing both 
mCherry-GR and either EGFP–ELL or EGFP–AFF4 were treated with 100 nM 
dexamethasone (Sigma) for 20 minutes. Imaging and FRAP experiments were per-
formed using a Zeiss LSM 5 Live Confocal Duoscan microscope with a ×63/1.4 oil 
immersion objective enclosed in a 5% CO2 and 37 °C humidified chamber. Identifica-
tion of MMTV arrays marked by the localization of mCherry-GR was achieved by 
exciting Cherry in the cells with the 561-nm 40-mW diode-pumped solid-state laser 
at 3% power. The mCherry emission was monitored with a LP 580 filter. Localization 
of EGFP–ELL or EGFP–AFF4 to the MMTV array was identified by exciting EGFP 
in the cells with the 488-nm 100-mW diode laser at 6% power. EGFP emission was 
monitored with a BP 495–555 filter. A nuclear region of interest containing the array 
was bleached with the 488 nm laser at 100% power. A single iteration was used for 
the bleach pulse lasting ~0.025 seconds. EGFP–ELL or EGFP–AFF4 was monitored 
every 0.250 s for 75 s with the 488 nm laser 6 % power to minimize photobleaching. 
Image series were included with 50 pre-bleach images for normalization of data. All 
FRAP curves were then normalized and averaged to generate an overall FRAP curve. 
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